PDL To Pay MedImmune $93M In IP Suit Over Synagis
PDL BioPharma Inc. said Wednesday it had agreed to pay MedImmune LLC $92.5 million to settle a patent lawsuit over MedImmune's respiratory treatment Synagis, in the wake of a January ruling...To view the full article, register now.
Already a subscriber? Click here to view full article